BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33972494)

  • 1. Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
    Jeong YH; Hwang S; Lee GD; Choi SH; Kim HR; Kim YH; Park SI; Kim DK
    Ann Transplant; 2021 May; 26():e930383. PubMed ID: 33972494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma.
    Nakamura A; Esaki M; Nakagawa K; Asakura K; Kishi Y; Nara S; Shimada K; Watanabe SI
    Gen Thorac Cardiovasc Surg; 2019 Sep; 67(9):782-787. PubMed ID: 30820914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Multiple Pulmonary Metastasectomy for Hepatocellular Carcinoma.
    Mizuguchi S; Nishiyama N; Izumi N; Tsukioka T; Komatsu H; Iwata T; Tanaka S; Takemura S; Kubo S
    World J Surg; 2016 Feb; 40(2):380-7. PubMed ID: 26306890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
    Ohba T; Yano T; Yoshida T; Kawano D; Tsukamoto S; Shoji F; Taketomi A; Saitsu H; Takeo S; Maehara Y
    Surg Today; 2012 Jun; 42(6):526-31. PubMed ID: 22173647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Analysis of Surgical Resection for Pulmonary Metastasis from Hepatocellular Carcinoma.
    Takahashi Y; Ikeda N; Nakajima J; Sawabata N; Chida M; Horio H; Okumura S; Kawamura M;
    World J Surg; 2016 Sep; 40(9):2178-85. PubMed ID: 27255943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Factors Predictive of a Better Prognosis of Pulmonary Metastasectomy for Hepatocellular Carcinoma.
    Wang L; Ye G; Zhan C; Sun F; Lin Z; Jiang W; Wang Q
    Ann Thorac Surg; 2019 Dec; 108(6):1685-1691. PubMed ID: 31445050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach.
    Lee HP; Yun JK; Jung HS; Moon DH; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
    World J Surg Oncol; 2021 Jan; 19(1):33. PubMed ID: 33516218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma.
    Kitano K; Murayama T; Sakamoto M; Nagayama K; Ueno K; Murakawa T; Nakajima J
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):376-82. PubMed ID: 21727012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.
    Kow AW; Kwon CH; Song S; Kim JM; Joh JW
    Surgery; 2015 Apr; 157(4):645-53. PubMed ID: 25794626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcome of pulmonary resection for metastases from hepatocellular carcinoma].
    Oyaizu T; Araki O; Karube Y; Hayama M; Seki N; Kobayashi S; Chida M
    Kyobu Geka; 2013 Apr; 66(4):302-4. PubMed ID: 23575182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary resection for metastases from hepatocellular carcinoma.
    Chen F; Sato K; Fujinaga T; Sonobe M; Shoji T; Sakai H; Miyahara R; Bando T; Okubo K; Hirata T; Date H
    World J Surg; 2008 Oct; 32(10):2213-7. PubMed ID: 18668285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma.
    Nakajima J; Tanaka M; Matsumoto J; Takeuchi E; Fukami T; Takamoto S
    World J Surg; 2005 Jun; 29(6):715-8. PubMed ID: 16078127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic significance and indications of pulmonary metastasectomy for hepatocellular carcinoma following liver resection.
    Hu Z; Li W; Huang P; Zhou Z; Xu J; Xu K; Wang J; Zhang H
    Int J Surg; 2017 Dec; 48():23-31. PubMed ID: 28987561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma.
    Yoon YS; Kim HK; Kim J; Choi YS; Shim YM; Paik SW; Kim K
    Ann Surg Oncol; 2010 Oct; 17(10):2795-801. PubMed ID: 20517683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma.
    Cho S; Ryu KM; Hwang YJ; Lee EB
    J Thorac Oncol; 2010 Aug; 5(8):1251-4. PubMed ID: 20588200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.